Tiphaine Vidal-Trecan Selected Research

Tiphaine Vidal-Trecan Research Topics

2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Melanoma (Melanoma, Malignant) 01/2018 - 11/2017
1	Lymphopenia (Lymphocytopenia) 10/2020
1	COVID-19 10/2020
1	Hypoglycemia (Reactive Hypoglycemia) 04/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Ischemia 01/2020
1	Virilism (Virilization) 01/2020
1	Retinal Neovascularization 01/2020
1	Insulin Resistance 01/2018
1	Gout 01/2018

1	InterferonsIBA 10/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	AntibodiesIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Immune Checkpoint InhibitorsIBA 11/2017
1	NivolumabIBA 11/2017

1	Critical Care (Surgical Intensive Care) 10/2020
1	Therapeutics 01/2020
1	Immunotherapy 01/2018
1	Duration of Therapy 01/2018
1	Punctures 01/2018